Laboratory_medicine
TriVerity
Inflammatix, Inc.
FDA-cleared AI medical device
A quantitative gene expression assay using reverse transcription polymerase chain reaction to quantify the relative expression levels of host response genes isolated from whole blood.
FDA Submission Metadata
- Submission number
- K241676
- Decision date
- January 2025
- FDA panel
- Microbiology
- Product code
- PRE
This entry is sourced from the FDA AI/ML-Enabled Medical Devices list. No editorial review yet — the catalogue may add a deeper review of this device in future.
This entry is on our editorial review queue. Full evaluation — performance metrics, clinical evidence, safety record — lands as our review pipeline graduates each device. The information above is what's been verified to date.